OncoDiag Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
8
OncoDiag General Information
Description
Developer of non-invasive diagnostic testing kits designed to help in the early detection of urological cancers. The company's testing kits consist of a urine-based lab test for the surveillance of bladder cancer, a tissue-based lab test to predict non-evolutive localized prostate cancer, and a blood-based lab test for screening colorectal cancer, enabling doctors to effectively proceed in cancer diagnostics.
Contact Information
Website
www.oncodiag.frCorporate Office
- 251 Rue Clément Ader
- Building A (door 9), Evreux
- 27000 Miserey
- France
Corporate Office
- 251 Rue Clément Ader
- Building A (door 9), Evreux
- 27000 Miserey
- France
OncoDiag Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 07-Jun-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 15-Mar-2021 | Completed | Generating Revenue | |||
| 4. Angel (individual) | 14-Dec-2018 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 06-Jun-2017 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 05-Jun-2014 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
OncoDiag Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 9,300 | $1.204024 | $24.08 | $24.08 | 1x | $24.08 | 5.96% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
OncoDiag Comparisons
Industry
Financing
Details
OncoDiag Competitors (4)
One of OncoDiag’s 4 competitors is DiaCarta, a Venture Capital-Backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DiaCarta | Venture Capital-Backed | Hayward, CA | ||||
| Owlstone Medical | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Nucleix | Venture Capital-Backed | Rehovot, Israel | ||||
| Biodesix | Formerly VC-backed | Louisville, CO |
OncoDiag Patents
OncoDiag Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026093495-A1 | Methods for the diagnosis of prostate cancer | Pending | 31-Oct-2024 | ||
| WO-2024208824-A1 | Methods for the diagnosis and surveillance of cancer | Inactive | 03-Apr-2023 | ||
| ES-2730710-T3 | Methods for surveillance, diagnosis and exploration of bladder cancer (bladder) | Active | 19-Nov-2013 | ||
| AU-2014352012-A1 | Methods for the surveillance, diagnosis and screening of bladder cancer | Active | 19-Nov-2013 | ||
| AU-2014352012-B2 | Methods for the surveillance, diagnosis and screening of bladder cancer | Inactive | 19-Nov-2013 | C12Q1/6886 |
OncoDiag Signals
OncoDiag Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| SATT Lutech | Accelerator/Incubator | |||
| Normandie Participations | Venture Capital | Minority | ||
| Paris Business Angels | Angel Group | Minority | ||
| SFINE | Venture Capital | Minority | ||
| Angels Santé | Angel Group | Minority |
OncoDiag FAQs
-
When was OncoDiag founded?
OncoDiag was founded in 2013.
-
Where is OncoDiag headquartered?
OncoDiag is headquartered in Miserey, France.
-
What is the size of OncoDiag?
OncoDiag has 7 total employees.
-
What industry is OncoDiag in?
OncoDiag’s primary industry is Diagnostic Equipment.
-
Is OncoDiag a private or public company?
OncoDiag is a Private company.
-
What is OncoDiag’s current revenue?
The current revenue for OncoDiag is .
-
How much funding has OncoDiag raised over time?
OncoDiag has raised $4M.
-
Who are OncoDiag’s investors?
SATT Lutech, Normandie Participations, Paris Business Angels, SFINE, and Angels Santé are 5 of 8 investors who have invested in OncoDiag.
-
Who are OncoDiag’s competitors?
DiaCarta, Owlstone Medical, Nucleix, and Biodesix are competitors of OncoDiag.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process